Deficiency of TMEM53 causes a previously unknown sclerosing bone disorder by dysregulation of BMP-SMAD signaling.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
06 04 2021
Historique:
received: 01 10 2020
accepted: 02 03 2021
entrez: 7 4 2021
pubmed: 8 4 2021
medline: 15 4 2021
Statut: epublish

Résumé

Bone formation represents a heritable trait regulated by many signals and complex mechanisms. Its abnormalities manifest themselves in various diseases, including sclerosing bone disorder (SBD). Exploration of genes that cause SBD has significantly improved our understanding of the mechanisms that regulate bone formation. Here, we discover a previously unknown type of SBD in four independent families caused by bi-allelic loss-of-function pathogenic variants in TMEM53, which encodes a nuclear envelope transmembrane protein. Tmem53

Identifiants

pubmed: 33824347
doi: 10.1038/s41467-021-22340-8
pii: 10.1038/s41467-021-22340-8
pmc: PMC8024261
doi:

Substances chimiques

Bone Morphogenetic Proteins 0
Membrane Proteins 0
Smad Proteins 0
TMEM53 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2046

Références

Dev Cell. 2002 Sep;3(3):439-49
pubmed: 12361605
Dev Biol. 1999 Apr 1;208(1):123-33
pubmed: 10075846
J Hum Genet. 2018 Jun;63(6):769-774
pubmed: 29568001
Am J Hum Genet. 2003 Mar;72(3):763-71
pubmed: 12579474
Cell Biosci. 2011 Dec 28;1(1):40
pubmed: 22204445
Nat Genet. 2006 May;38(5):525-7
pubmed: 16642017
J Biol Chem. 2003 Sep 5;278(36):34387-94
pubmed: 12815054
Science. 2003 Sep 5;301(5638):1380-2
pubmed: 12958361
J Biol Chem. 2002 Feb 15;277(7):4883-91
pubmed: 11729207
Nat Methods. 2012 Jun 28;9(7):637
pubmed: 22743765
Nat Genet. 2000 Sep;26(1):19-20
pubmed: 10973241
Trends Biochem Sci. 2017 Feb;42(2):98-110
pubmed: 27712956
Am J Med Genet A. 2010 Sep;152A(9):2335-8
pubmed: 20684007
PLoS One. 2011 Apr 14;6(4):e18762
pubmed: 21533191
Am J Hum Genet. 2019 May 2;104(5):925-935
pubmed: 30982609
J Bone Miner Res. 2000 Dec;15(12):2413-30
pubmed: 11127206
Hum Mol Genet. 2001 Mar 1;10(5):537-43
pubmed: 11181578
J Korean Neurosurg Soc. 2016 May;59(3):192-6
pubmed: 27226848
Am J Med Genet A. 2019 Dec;179(12):2393-2419
pubmed: 31633310
PLoS One. 2013 Apr 30;8(4):e62721
pubmed: 23646137
Cytokine Growth Factor Rev. 2016 Feb;27:129-39
pubmed: 26747371
Hum Mol Genet. 2014 Jun 1;23(11):3054-68
pubmed: 24430505
Nat Genet. 2004 Nov;36(11):1213-8
pubmed: 15489854
Hum Genet. 2011 May;129(5):497-502
pubmed: 21221996
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Genome Res. 2010 Jan;20(1):36-44
pubmed: 19926752
Am J Med Genet A. 2010 Apr;152A(4):870-4
pubmed: 20358596
J Bone Miner Res. 2019 Jul;34(7):1275-1283
pubmed: 30779856
Cell. 2001 Jan 26;104(2):205-15
pubmed: 11207362
Cell Mol Life Sci. 2010 Apr;67(8):1353-69
pubmed: 20091084
Nat Genet. 2011 Dec 11;44(1):85-8
pubmed: 22158539
Genes Dis. 2014 Sep;1(1):120-125
pubmed: 25426492
Nucleic Acids Res. 2002 Jan 15;30(2):515-22
pubmed: 11788714
Orphanet J Rare Dis. 2017 Aug 30;12(1):147
pubmed: 28854936
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12277-82
pubmed: 14523231
J Biol Chem. 2005 Oct 21;280(42):35579-87
pubmed: 16115867
N Engl J Med. 2016 Jun 30;374(26):2553-2562
pubmed: 27355534

Auteurs

Long Guo (L)

Laboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan. longguo601@gmail.com.

Aritoshi Iida (A)

Laboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.
Department of Clinical Genome Analysis, Medical Genome Center, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.

Gandham SriLakshmi Bhavani (GS)

Department of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India.

Kalpana Gowrishankar (K)

Kanchi Kamakoti CHILDS Trust Hospital, Tamil Nadu, India.

Zheng Wang (Z)

Laboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.
Department of Medical Genetics, Institute of Basic Medical Sciences, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

Jing-Yi Xue (JY)

Laboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.
Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Juan Wang (J)

Laboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.
Department of Ultrasound, The Second Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an, China.

Noriko Miyake (N)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Naomichi Matsumoto (N)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Takanori Hasegawa (T)

Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Yusuke Iizuka (Y)

Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Masashi Matsuda (M)

Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Tomoki Nakashima (T)

Department of Cell Signaling, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Masaki Takechi (M)

Department of Molecular Craniofacial Embryology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Sachiko Iseki (S)

Department of Molecular Craniofacial Embryology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Shinsei Yambe (S)

Department of Molecular Biology and Biochemistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Gen Nishimura (G)

Laboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan.

Haruhiko Koseki (H)

Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Chisa Shukunami (C)

Department of Molecular Biology and Biochemistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Katta M Girisha (KM)

Department of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India. girish.katta@manipal.edu.

Shiro Ikegawa (S)

Laboratory for Bone and Joint Diseases, RIKEN Center for Integrative Medical Sciences, Tokyo, Japan. sikegawa@ims.u-tokyo.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH